Detecting Reporting Resistance in Fastidious Bacteria - SWACM
Detecting Reporting Resistance in Fastidious Bacteria - SWACM Detecting Reporting Resistance in Fastidious Bacteria - SWACM
CLSI M45-A2 Table 1 Abiotrophia / Granulicatella Derivation of interpretive criteria (breakpoints)….
How were interpretive criteria (breakpoints) established? Searched literature Surveyed experience of working group members Performed limited studies Adapted breakpoints from similar bugs in M100, when appropriate Did NOT use extensive microbiological, clinical, and pharmacodynamic databases that are typically used to set breakpoints (described in CLSI M23 document)
- Page 1 and 2: Detecting / Reporting Resistance in
- Page 3 and 4: CLSI M45-A2 Guideline Abiotrophia /
- Page 5 and 6: Organisms Included in CLSI M45-A2 M
- Page 7 and 8: Table 17. Summary of Testing Condit
- Page 9 and 10: Can we test M45-A2 organisms with a
- Page 12 and 13: Qualifying Results Optional Comment
- Page 14 and 15: Abiotrophia spp. / Granulicatella s
- Page 16 and 17: CLSI M45-A2 Table 1 Abiotrophia / G
- Page 20 and 21: “S” only breakpoint Abiotrophia
- Page 22 and 23: Specimen: Blood Diagnosis: Endocard
- Page 24 and 25: Coryneforms and Corynebacterium spp
- Page 26 and 27: Specimen: Bone marrow Diagnosis: Le
- Page 28 and 29: CLSI M45-A2 Table 13 Pasteurella sp
- Page 30 and 31: Why should we do -lactamase test on
- Page 32 and 33: -Lactamase Testing of M45 Bugs Reco
- Page 34 and 35: Specimen: Cerebrospinal fluid Diagn
- Page 36 and 37: Procedure used in some labs to expe
- Page 38 and 39: HACEK Group Haemophilus aphrophilus
- Page 40 and 41: Specimen: Blood Diagnosis: Endocard
- Page 42 and 43: Moraxella catarrhalis “If desired
- Page 44 and 45: Outcomes of Single Dose Azithromyci
- Page 46 and 47: Table 17. Summary of Testing Condit
- Page 48 and 49: Minimum Laboratory Requirements for
CLSI M45-A2 Table 1<br />
Abiotrophia / Granulicatella<br />
Derivation of <strong>in</strong>terpretive criteria (breakpo<strong>in</strong>ts)….
Change language